Keywords: لنفوم غیر هودقین; Non-Hodgkin's lymphoma; Liver neoplasm; Hepatic lymphoma; Therapy; Surgery;
مقالات ISI لنفوم غیر هودقین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لنفوم غیر هودقین; Non-Hodgkin's lymphoma; Lymphatic malignancies; Body mass index; Adiposity; Obesity; Overweight; Height; Meta-analysis;
Keywords: لنفوم غیر هودقین; Self-rated health; Non-Hodgkin's lymphoma; Elderly patients;
Keywords: لنفوم غیر هودقین; γc; common gamma chain, CD132; IL; interleukin; sγc; soluble form of common gamma chain; JAK; Janus-activated kinase; STAT; signal transducer and activator of transcription; T-ALL; T-cell acute lymphocytic leukemia; B-ALL; B-cell acute lymphocytic leuke
Keywords: لنفوم غیر هودقین; Qigong; Exercise; Non-Hodgkin's lymphoma; Fatigue; Sleep quality;
Keywords: لنفوم غیر هودقین; DLBCL; diffuse large B cell lymphoma; GM-CSF; granulocyte macrophage colony-stimulating factor; IFN-γ; interferon γ; IL; interleukin; IP-10; IFN-γ induced protein-10; KC-like; keratinocyte chemoattractant-like; MCP-1; monocyte chemoattractant protein-1
Keywords: لنفوم غیر هودقین; Cancer Risk; Ulcerative Colitis; Crohn's Disease; Treatment; AZA; azathioprine; CESAME; Cancers Et Surrisque Associé aux Maladies inflammatoires intestinales En France; CI; confidence interval; EBV; Epstein-Barr virus; ENEIDA; Española de Enfermedad
Keywords: لنفوم غیر هودقین; Chemotherapy; Involved field radiation therapy; Involved node radiation therapy; Non-Hodgkin's lymphoma; Malignant lymphoma;
Role of radiotherapy in patients with limited diffuse large B-cell lymphoma of Waldeyer's ring in remission after R-CHOP immunochemotherapy
Keywords: لنفوم غیر هودقین; WR; Waldeyer's ring; NHL; non-Hodgkin's lymphoma; DLBCL; diffuse large B-cell lymphoma; RT; radiotherapy; IFRT; Involved field radiation therapy; CT; immunochemotherapy; PET-CT; positron emission tomography-computed tomography; DFS; disease free survi
Sex-specific survival difference in association with HLA-DRB1â04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies
Keywords: لنفوم غیر هودقین; Allogeneic HSCT; HLA allele groups; Lymphoid malignancy; Survival; HLA-DRB1â04; Allo-HSCT; allogeneic haematopoietic stem cell transplantation; ALL; acute lymphoid leukaemia; CI; confidence interval; CLL; chronic lymphoid leukaemia; CMV; cytomegalovirus
Diagnostic accuracy of 18-F FDG-PET/CT in evaluation of malignant neuronal involvement in neurologically manifested cancer patients
Keywords: لنفوم غیر هودقین; PET/CT; Perineural spread; Malignant neuronal involvement; 18F; fluorine-18; CT; computed tomography; FDG; fluorodeoxyglucose; GBM; glioblastoma multiformis; MIP; maximum intensity projection; MRI; magnetic resonance imaging; NHL; Non-Hodgkin's lymphoma
Rituximab desensitization in three patients with severe rituximab allergy
Keywords: لنفوم غیر هودقین; Biologic; Desensitization; Drug allergy; Non-Hodgkin's lymphoma; Rituximab;
The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients
Keywords: لنفوم غیر هودقین; IgM monoclonal gammopathy; Waldenstrom macroglobulinemia; Non-Hodgkin's lymphoma; Monoclonal gammopathy of undetermined significance;
Radioimmunotherapy in non-Hodgkin lymphoma: Prediction and assessment of response
Keywords: لنفوم غیر هودقین; Radioimmunotherapy; Non-Hodgkin's lymphoma; Prediction of response; Assessment of response; Patient selection; Prognostic factors; Imaging; Risk assessment;
Primary immunodeficiencies and B-cell lymphomas
Keywords: لنفوم غیر هودقین; Antitumor immunity; Common variable immunodeficiency; B lymphomas; Non-Hodgkin's lymphoma; Epstein-Barr virus; Inmunidad antitumoral; Inmunodeficiencia variable común; Linfomas B; Linfoma no Hodgkin; Virus Epstein-Barr;
Zevalin® (ibritumomab tiuxetan): After more than a decade of treatment experience, what have we learned?
Keywords: لنفوم غیر هودقین; Zevalin; Ibritumomab tiuxetan; Non-Hodgkin's lymphoma; Radioimmunotherapy;
The Cost-effectiveness of Pixantrone for Third/Fourth-line Treatment of Aggressive Non-Hodgkin's Lymphoma
Keywords: لنفوم غیر هودقین; cost-effectiveness; non-Hodgkin's lymphoma; pixantrone; survival analysis;
Effect of R-CHOP chemotherapy on liver and mediastinal blood pool 18F-FDG standardized uptake values in patients with non-Hodgkin's lymphoma
Keywords: لنفوم غیر هودقین; PET; Non-Hodgkin's lymphoma; Chemotherapy; R-CHOP; Standardized uptake value;
Targeted antisense radiotherapy and dose fractionation using a 177Lu-labeled anti-bcl-2 peptide nucleic acid-peptide conjugate
Keywords: لنفوم غیر هودقین; Non-Hodgkin's lymphoma; bcl-2; Lutetium-177; Peptide nucleic acid; Targeted antisense radiotherapy;
Natural Killer/T-Cell Lymphoma, Nasal Type, Masquerading as Recalcitrant Periodontitis in a Patient With a Diagnosis of Wegener's Granulomatosis
Keywords: لنفوم غیر هودقین; Extranodal NK/T-cell lymphoma; Nasal lymphoma; Wegener's granulomatosis; non-Hodgkin's lymphoma; Lethal midline granuloma;
Outcomes of Patients With Non-Hodgkin's Lymphoma Treated With Bexxar With or Without External-Beam Radiotherapy
Keywords: لنفوم غیر هودقین; Chemotherapy; Iodine-131; Tositumomab; Bexxar; Non-Hodgkin's lymphoma;
Anti-CD20 multivalent HPMA copolymer-Fabâ² conjugates for the direct induction of apoptosis
Keywords: لنفوم غیر هودقین; HPMA; CD20; Non-Hodgkin's lymphoma; Rituximab; B cell; Multivalency;
Application of vitamin D and derivatives in hematological malignancies
Keywords: لنفوم غیر هودقین; MDS; myelodysplastic syndrome (preleukemia); AML; acute myelogenous leukemia; CML; chronic myelogenous leukemia; CMML; chronic myelomonocytic leukemia; NHL; non-Hodgkin's lymphoma; Vitamin D; Hematological malignancies; Intracellular kinases; Multiple m
Full-Term Pregnancy and Vaginal Delivery After Treatment for Non-Hodgkin's Lymphoma of the Cervix and Lower Uterine Segment: A Case Report
Keywords: لنفوم غیر هودقین; Non-Hodgkin's lymphoma; vaginal delivery; pregnancy;
High levels of BACH2 associated with lower levels of BCL2 transcript abundance in t(14;18)(q21;q34) translocation positive non-Hodgkin's lymphoma
Keywords: لنفوم غیر هودقین; Non-Hodgkin's lymphoma; Follicular lymphoma; Diffuse large B-cell lymphoma; BACH2; BCL2; t(14 ;18)(q21 ;q34);
Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in Spain
Keywords: لنفوم غیر هودقین; Linfomas no hodgkinianos; SÃndromes linfoproliferativos; Infiltración del sistema nerviosocentral; Intratecal; Profilaxis; Tratamiento; Non-Hodgkin's lymphoma; Lymphoproliferative disorders; Central nervous system involvement; Intrathecal; Prophylaxis
Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma
Keywords: لنفوم غیر هودقین; NHL; non-Hodgkin's Lymphoma; DFS; disease free-survival; OS; overall-survival; SVR; sustained virological response; Non-Hodgkin's lymphoma; Hepatitis C antiviral therapy;
Sclerosing Mesenteritis: Clinical Features, Treatment, and Outcome in Ninety-Two Patients
Keywords: لنفوم غیر هودقین; CT; computed tomography; IQR; interquartile range; MGUS; monoclonal gammopathy of unknown significance; NHL; non-Hodgkin's lymphoma; RPF; retroperitoneal fibrosis; SM; sclerosing mesenteritis; SP; sclerosing pancreatitis; TGF-β; transforming growth fac
Treatment with Rituximab in Benign and Malignant Hematologic Disorders in Children
Keywords: لنفوم غیر هودقین; ADCC; Antibody-dependent cellular cytotoxicity; AIHA; Autoimmune hemolytic anemia; ALL; Acute lymphoblastic leukemia; CR; Complete response; IFN; Interferon; IL; Interleukin; ITP; Immune thrombocytopenic purpura; IVIG; Intravenous immune globulin; NHL; No
In Vivo Monitoring Response to Chemotherapy of Human Diffuse Large B-Cell Lymphoma Xenografts in SCID Mice by 1H and 31P MRS
Keywords: لنفوم غیر هودقین; Non-Hodgkin's lymphoma; chemotherapy; therapeutic response; MRS; lactate; choline;
Logistics of therapy with the ibritumomab tiuxetan regimen
Keywords: لنفوم غیر هودقین; Ibritumomab tiuxetan; Radioimmunotherapy; Non-Hodgkin's lymphoma;
Periportal Lymphadenopathy in Patients Without Identifiable Pancreatobiliary or Hepatic Malignancy
Keywords: لنفوم غیر هودقین; CLL; chronic lymphocytic leukemia; CT; computerized tomography; EUS; endoscopic ultrasound; FNA; fine-needle aspiration; HCC; hepatocellular carcinoma; MRI; magnetic resonance imaging; NHL; non-Hodgkin's lymphoma;
Case Report: Lymphoma Arising in an Ileal Pouch Anal Anastomosis After Immunomodulatory Therapy for Inflammatory Bowel Disease
Keywords: لنفوم غیر هودقین; 6-MP; 6-mercaptopurine; ASA; aminosalicylate; AZA; azathioprine; CSA; cyclosporine; EBV; Epstein-Barr virus; FDA; Food and Drug Administration; IBD; inflammatory bowel disease; IPAA; ileal pouch anal anastomosis; NHL; non-Hodgkin's lymphoma; RA; rheumat
Iodine-131 tositumomab (Bexxar) in a radiation oncology environment
Keywords: لنفوم غیر هودقین; Iodine-131 tositumomab; Bexxar; Non-Hodgkin's lymphoma;
Notas clÃnicasLinfomas primarios del timoPrimary thymic lymphomas
Keywords: لنفوم غیر هودقین; timo; enfermedad de Hodgkin; linfoma no Hodgkin; linfoma primario mediastÃnico de células B; linfoma linfoblástico; cirugÃa; quimioterapia; radioterapia; thymus; Hodgkin's disease; non-Hodgkin's lymphoma; primary mediastinal B-cell lymphoma; lymph
Whole-abdomen radiotherapy for non-Hodgkin's lymphoma using twice-daily fractionation
Keywords: لنفوم غیر هودقین; Non-Hodgkin's lymphoma; Radiotherapy; Whole-abdomen radiotherapy; Fractionation; Toxicity;
Primary spinal epidural lymphoma: Patients' profile, outcome, and prognostic factors: A multicenter Rare Cancer Network study
Keywords: لنفوم غیر هودقین; Primary spinal epidural lymphoma; Non-Hodgkin's lymphoma; Spinal cord compression; Radiation therapy; Chemotherapy; Combined modality treatment;
Ongoing investigations and new uses of radioimmunotherapy in the treatment of non-Hodgkin's lymphoma
Keywords: لنفوم غیر هودقین; Radionuclide therapy; Ibritumomab tiuxetan; Tositumomab; non-Hodgkin's lymphoma;
Influence of familial cancer history on lymphoid neoplasms risk validated in the large European case-control study epilymph
Keywords: لنفوم غیر هودقین; Case-control study; Familial cancer; Non-Hodgkin's lymphoma; Hodgkin's lymphoma; Chronic lymphocytic leukaemia;
Treatment and survival for non-Hodgkin's lymphoma: Influence of histological subtype, age, and other factors in a population-based study (1999-2001)
Keywords: لنفوم غیر هودقین; Chemotherapy; Non-Hodgkin's lymphoma; Patterns of care; Radiotherapy; Survival;
Linfoma no Hodgkin y aparato urinario. A propósito de un caso
Keywords: لنفوم غیر هودقین; Linfoma no Hodgkin; Linfoma de células B; Linfoma urológico; Cáncer genito-urinario; Non-Hodgkin's lymphoma; B-Cell Lymphoma; Urological lymphoma; Urological lymphoma;
Fludarabine phosphate-CVP in patients over 60 years of age with advanced, low-grade and follicular lymphoma: A dose-finding study
Keywords: لنفوم غیر هودقین; Fludarabine phosphate; Non-Hodgkin's lymphoma; Follicular lymphoma;
Gamma camera scans and pretreatment tumor volumes as predictors of response and progression after Y-90 anti-CD20 radioimmunotherapy
Keywords: لنفوم غیر هودقین; Ibritumomab tiuxetan; Non-Hodgkin's lymphoma; Radioimmunotherapy;
Medical history and risk for lymphoma: results of a population-based case-control study in Germany
Keywords: لنفوم غیر هودقین; Hodgkin's lymphoma; Non-Hodgkin's lymphoma; Diffuse large B-cell lymphoma; Follicular lymphoma; B-CLL; MALT lymphoma; Multiple myeloma; B-NHL; T-NHL; Urticaria;
Follicular lymphoma: time for a re-think?
Keywords: لنفوم غیر هودقین; Follicular lymphoma; Non-Hodgkin's lymphoma; Rituximab; CD20; BCL-2; Bexxar; Zevalin; Anti-idiotype vaccination; Fludarabine; Cyclophosphamide; Anthracycline;
Tolerability and safety of rituximab (MabThera®)
Keywords: لنفوم غیر هودقین; Rituximab; CD20; Immunotherapy; Immunochemotherapy; Non-Hodgkin's lymphoma; Chronic lymphocytic leukaemia; Rheumatoid arthritis;